Alterola Biotech, Inc. (ABTI) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Birkenhead, イギリス. 現CEOは David John Hitchcock.
ABTI を有する IPO日 2010-05-05, 1 名の正社員, に上場 Other OTC, 時価総額 $7.44M.
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.
